Status:
RECRUITING
Prognosis and Risk Factors for Acute Kidney Injury
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Seoul National University Bundang Hospital
SMG-SNU Boramae Medical Center
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
20+ years
Brief Summary
The aim of our study is to analyze the accurate diagnosis and prognosis of acute kidney injury (AKI) based on its severity and to define long-term clinical and socioeconomic outcomes. Investigators d...
Eligibility Criteria
Inclusion
- Adults over 20 years old who visited Parcitipating Medical Center (Seoul National University Hospital, Bundang Seoul National University Hospital, SMG-SNU Boramae Medical Center, Keimyung University Dongsan Medical Center) between 2006 and 2021
- The AKI group is defined as individuals meeting the AKI diagnostic criteria of the KDIGO Guideline (an increase in serum creatinine of ≥0.3 mg/dL or ≥1.5 times the baseline level) is enrolled.
- The Control Group is defined as individuals from the study population who do not meet the AKI criteria and are matched 1:1 based on age, sex, year of visit, and baseline renal function.
Exclusion
- Individuals under 20 years old
- Individuals who did not undergo serum creatinine tests meeting the criteria
- Individuals with pre-existing end-stage kidney disease (ESKD) who have undergone dialysis or kidney transplantation
Key Trial Info
Start Date :
August 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
320000 Patients enrolled
Trial Details
Trial ID
NCT06898944
Start Date
August 22 2022
End Date
December 31 2026
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080